Friday Five: Caris Life Sciences hits MCED market on July 05, 2026 AI drug discovery Anthropic Axelios sequencer Biological Assay Caris Detect CARIS Life Sciences Claude Science Everlywell Illumina MCED next-generation sequencing Precision Medicine Roche (company) +
Illumina Acquires SomaLogic to Accelerate Proteomics Strategy with $350M Upfront on June 24, 2025 Acquisition Biotechnology Illumina Proteomics SomaLogic Standard BioTools +
Citing tariffs, Illumina slashes guidance, confirms SEC's Grail investigation is closed on May 09, 2025 Acquisition (action) divestiture Evaluation Grail Illumina SEC +
Illumina and Tempus look beyond cancer in new AI-driven genomics deal on April 16, 2025 Artificial Intelligence Cardiology discipline Genetic Profile Genomics High-Throughput Nucleotide Sequencing Illumina Immunology Malignant Neoplasms Neurology speciality Partnership +
Illumina Reshapes Board: Former FDA Chief Takes Chair, Activist Investor Joins on March 25, 2025 board changes Genomics Illumina Keith Meister Scott Gottlieb shareholder +
Illumina Announces Layoffs as Incyte Forges AI Partnership for Drug Discovery on February 24, 2025 Artificial Intelligence Drug Discovery FOXD3 gene Gemini of Coiled Bodies Illumina Incyte Partnership +
Illumina's Double-Edged Sword: Navigating US-China Trade Tensions on February 07, 2025 BIOSECURE China DNA Sequence Entity Illumina Industry Tension TNFRSF19 gene unreliable +